Journal of the Korean neurological association (대한신경과학회지)

Korean Neurological Association (대한신경과학회)
권호 표지

Olfactory Function and Its Correlation with Cardiac $^{123}I-MIBG$ in Patients with Parkinson's Disease and Multiple System Atrophy

파킨슨병과 다계통 위축증 환자들에서 후각기능 및 후각기능과 심장 $^{123}I-MIBG$섭취율과의 연관성

Yeo, Seung-Hyeon;Shin, Dong-Hoon;Kim, Hyun-Joon;Lee, Phil-Hyu
여승현;신동훈;김현준;이필휴

  • Published : 2007.02.01
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Ansari KA, Johnson A. Olfactory function in patients with Parkinson's disease. J Chron Dis 1975;28:493-497 https://doi.org/10.1016/0021-9681(75)90058-2
  2. Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988;38:1237-1244 https://doi.org/10.1212/WNL.38.8.1237
  3. Hawkes CH, Shephard BC, Daniel SE. Is Parkinson's disease a primary olfactory disorder? QJM 1999;92:473-480 https://doi.org/10.1093/qjmed/92.8.473
  4. Double KL, Rowe DB, Hayes M, Chan DK, Blacke J, Corbett A, et al. Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Arch Neurol 2003; 60:545-549 https://doi.org/10.1001/archneur.60.4.545
  5. Ward CD, Hess WA, Calne DB. Olfactory impairment in Parkinson's disease. Neurology 1983;33:943-946 https://doi.org/10.1212/WNL.33.7.943
  6. Quinn NP, Rossor MN, Marsden CD. Olfactory threshold in Parkinson's disease. J Neurol Neurosurg Psychiatry 1987;50:88-89 https://doi.org/10.1136/jnnp.50.1.88
  7. Doty RL, Stern MB, Pfeiffer C, Gollimp SM, Hurtig HI. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1992; 55:138-142 https://doi.org/10.1136/jnnp.55.2.138
  8. Hawkes CH, Shephard BC, Daniel SE. Olfaction dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;62:436-446 https://doi.org/10.1136/jnnp.62.1.38
  9. Tissingh G, Berendse HW, Bergmans P, DeWaard R, Drukarch B, Stoof JC, et al. Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis. Mov Disord 2001;16:41-46 https://doi.org/10.1002/1531-8257(200101)16:1<41::AID-MDS1017>3.0.CO;2-M
  10. Daniel SE, Hawkes CH. Preliminary diagnosis of Parkinson's disease using olfactory bulb pathology. Lancet 1992;340:186 https://doi.org/10.1016/0140-6736(92)92436-J
  11. Pearce RK, Hawkes CH, Daniel SE. The anterior olfactory nucleus in Parkinson's disease. Mov Disord 1995;10:283-287 https://doi.org/10.1002/mds.870100309
  12. Markopoulou K, Larsen KW, Wszolek EK, Denson MA, Lang AE, Pfeiffer RF, et al. Olfactory dysfunction in familial parkinsonism. Neurology 1997;49:1262-1267 https://doi.org/10.1212/WNL.49.5.1262
  13. Berendse HW, Booij J, Francot CM, Bergmans PL, Hijman R, Stoof JC, et al. Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell. Ann Neurol 2001;50:34-41 https://doi.org/10.1002/ana.1178
  14. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters ECh, Berendse HW. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004;56:173-181 https://doi.org/10.1002/ana.20160
  15. Jaques S Jr, Tobes MC, Sisson JC, Baker JA, Wieland DM. Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells. Mol Pharmacol 1984;26:539-546
  16. Wieland DM, Brown LE, Tobes MC, Rogers WL, Marsh DD, Mangner TJ, et al. Imaging the primate adrenal medulla with [123I] and [131I] meta-iodobenzylguanidine: concise communication. J Nucl Med 1981;22:358-364
  17. Braune S, Reinhardt M, Schnitzer R, Riedel A, Lucking CH. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology 1999;53:1020-1025 https://doi.org/10.1212/WNL.53.5.1020
  18. Druschky A, Hilz MJ, Platsch G, Radespiel-Troger M, Druschky K, Kuwert T, et al. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci 2000;175:3-12 https://doi.org/10.1016/S0022-510X(00)00279-3
  19. Hawkes C. Olfaction in neurodegenerative disorder. Mov Disord 2003;18:364-372 https://doi.org/10.1002/mds.10379
  20. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinsonism-a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184 https://doi.org/10.1136/jnnp.55.3.181
  21. Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98 https://doi.org/10.1016/S0022-510X(98)00304-9
  22. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442 https://doi.org/10.1212/WNL.17.5.427
  23. Fahn S, Elton RL, UPDRS program members. Unified Parkinsons Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, editors. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan Healthcare Information, 1987:153-163
  24. Doty RL, Marcus A, Lee WW. Development of the 12-Item Cross-Cultural Smell Identification Test (CC-SIT). Laryngoscope 1996;106:353-356 https://doi.org/10.1097/00005537-199603000-00021
  25. Double KL, Rowe DB, Hayes M, Chan DK, Blacke J, Corebett A, et al. Identifying the pattern of olfactory deficits in parkinson disease using the brief smell identification test. Arch Neurol 2003; 60:545-549 https://doi.org/10.1001/archneur.60.4.545
  26. Donald AL. Physiology of olfaction. In: Cummings CW, Fredrickson JM, Harker AL, Krause CJ, Richardon MA, Schuller DE, editor. Otolaryngolgy-Head and Neck Surgery. 4rd ed. Vol. 2. Louis: Mosby year book, 2004:844-851, 865-897
  27. Satoh A, Serita T, Seto M, Tomita I, Satoh H, Iwanaga K, et al. Loss of $^{123}I$-metaiodobenzylguanidine (MIBG) uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value. J Nucl Med 1999;40:371-375
  28. Hawkes C. Olfaction in neurodegenerative disorder. Adv Otorhinolaryngol 2006;63:133-51
  29. Wenning GK, Shephard B, Hawkes C, Petruckevitch A, Lees A, Quinn N. Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand 1995;91:247-250 https://doi.org/10.1111/j.1600-0404.1995.tb08129.x
  30. Muller A, Reichmann H, Livermore A, Hummel T. Olfactory function in idiopathic Parkinson's disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients. J Neural Transm 2002;109:805-811 https://doi.org/10.1007/s007020200067
  31. Double KL, Rowe DB, Hayes M, Chan DK, Blackie J, Corbett A, et al. Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Arch Neurol 2003; 60:545-549 https://doi.org/10.1001/archneur.60.4.545
  32. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211 https://doi.org/10.1016/S0197-4580(02)00065-9
  33. Saiki S, Hirose G, Sakai K, Kataoka S, Hori A, Saiki M, et al. Cardiac $^{123}I$-MIBG scintigraphy can assess the disease severity and phenotype of PD. J Neurol Sci 2004;220:105-111 https://doi.org/10.1016/j.jns.2004.02.018
  34. Spiegel J, Mollers MO, Jost WH, Fuss G, Samnick S, Dillmann U, et al. FP-CIT and MIBG scintigraphy in early Parkinson's disease. Mov Disord 2005;20:552-561 https://doi.org/10.1002/mds.20462
  35. Iwanga K, Wakabaysxhi K, Yoshimoto M, Tomita I, Satoh H, Takashima H, et al. Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases. Neurology 1999;52:1269-1271 https://doi.org/10.1212/WNL.52.6.1269
  36. Kovacs T, Papp MI, Cairns NJ, Khan MN, Lantos PL. Olfactory bulb in multiple system atrophy. Mov Disord 2003;18:938-942 https://doi.org/10.1002/mds.10466